Welcome to Lamellar Biomedical
Lamellar is developing a range of patent protected medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies. Diseases which may benefit from the application of Lamellasome™ mimetics of the body’s lamellar bodies include Dry Mouth, Dry Eye and Cystic Fibrosis. All these conditions are poorly served by current medications and represent areas of high value unmet medical need.Learn more
Research & Development
Lamellar in partnership with clinical centres-of-excellence is highly advanced in developing novel products for Dry Mouth, Dry Eye and Cystic Fibrosis.Learn more
Lamellar Biomedical Shareholders comprise both institutional and private investors.Learn more
News & Press
What has been going on at Lamellar?Learn more
An innovative, biotechnology company bringing new patent protected medical devices and pharmaceutical products to the healthcare market.
To successfully develop and commercialise multiple medical devices and pharmaceuticals based on Lamellar’s proprietary Lamellasome™ technology.
Lamellar's patented Lamellasome™ technology has the ability play an important role in treating a broad range of poorly served medical conditions.